Molecular Epidemiology of Plasmodium falciparum kelch13 Mutations in Senegal Determined by Using Targeted Amplicon Deep Sequencing
Author(s) -
Eldin Talundzic,
Yaye Dié Ndiaye,
Awa B. Dème,
Christian A. Olsen,
Dhruviben Patel,
Shweta Biliya,
Rachel F. Daniels,
Fredrik Vannberg,
Sarah K. Volkman,
Venkatachalam Udhayakumar,
Daouda Ndiaye
Publication year - 2017
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.02116-16
Subject(s) - plasmodium falciparum , biology , amplicon , artemisinin , genetics , drug resistance , malaria , context (archaeology) , population , virology , gene , medicine , polymerase chain reaction , immunology , environmental health , paleontology
The emergence ofPlasmodium falciparum resistance to artemisinin in Southeast Asia threatens malaria control and elimination activities worldwide. Multiple polymorphisms in theP. falciparum kelch gene found in chromosome 13 (Pfk13 ) have been associated with artemisinin resistance. Surveillance of potential drug resistance loci within a population that may emerge under increasing drug pressure is an important public health activity. In this context,P. falciparum infections from an observational surveillance study in Senegal were genotyped using targeted amplicon deep sequencing (TADS) forPfk13 polymorphisms. The results were compared to previously reportedPfk13 polymorphisms from around the world. A total of 22Pfk13 propeller domain polymorphisms were identified in this study, of which 12 have previously not been reported. Interestingly, of the 10 polymorphisms identified in the present study that were also previously reported, all had a different amino acid substitution at these codon positions. Most of the polymorphisms were present at low frequencies and were confined to single isolates, suggesting they are likely transient polymorphisms that are part of naturally evolving parasite populations. The results of this study underscore the need to identify potential drug resistance loci existing within a population, which may emerge under increasing drug pressure.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom